Oculus Innovative Sciences (OCLS):Creates Breakthrough for Laser Skincare Patients

Stephen L Kanaval  |

After having laser treatment, many patients experience extreme inching to the contact areas. Some, and you can Google this and read accounts for yourself, as awake-me-up-in-the-middle-of-the-night itching. The real issue here is that the itching can put the treatment area at risk for healing properly, if a patient cannot control themselves or find a suitable remedy. Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions has created a skincare solution to help patients fighting the nagging itching.

The product is called Lasercyn™ and it is designed to help patient manage post-non-ablative laser therapy procedures, post-microdermabrasion therapy and following superficial chemical peels. The product can also relieve pain and itching from minor skin irritation, lacerations and minor burns. "Lasercyn is a promising new tool for all aesthetic dermatologists who are looking to better manage post-laser itch and pain associated with laser skin resurfacing, while promoting enhanced healing and protection against secondary infections. In our clinical testing of Lasercyn to date, we have seen dramatically improved outcomes with quicker healing times and less patient discomfort when Lasercyn is added to the post-procedure management protocol," said Dr. Michael Gold, a board-certified dermatologist and cosmetic surgeon out of Nashville, Tennessee who runs the Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center.

Many people are turning away from plastic surgery to rejuvenate skin and in 2015 laser skin care rose 22%. Besides the pain of itching, the benefit of laser skin care tempts many because it is fast, low risk and affordable. With a solution from Oculus, many surgeons and skincare centers could be recommending the Lasercyn product to further coax patients into the safety of laser skin procedures.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
OCLS Metro Inc. n/a n/a n/a n/a
OCLSW Oculus Innovative Sciences Inc. Warrants n/a n/a n/a n/a

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Fintech - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Financial Market Infrastructure